Rune Labs
PrivateLast Round
Series A
Extension
Jan 11, 2024
Total Funding Raised
$42.1M
Company Overview
Rune Labs operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Series A Extension round in January 2024.
Rune Labs is a healthcare technology company that provides a software and data analytics platform for precision neurology to support care delivery and therapy development.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Healthcare Analytics, Precision Medicine, Medical Devices, Health IoT
Business Model
B2B
Customer Profile
Data as a Service, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rune Labs Comparables
Compare Rune Labs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NeuroRPM | 91% | |
| h2o Therapeutics | 80% | |
| Great Lakes NeuroTechnologies Inc. | 79% |
For institutional investors. Book with your work email.
Rune Labs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jan 11, 2024 | ||||
| Series A | Sep 16, 2021 | ||||
| Seed | Oct 26, 2020 | ||||
| Pre Seed | Sep 3, 2019 |
For institutional investors. Book with your work email.
Rune Labs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DigiTx Partners | Series A, Series A Extension, Seed |
| Moment Ventures | Series A, Series A Extension, Pre Seed, Seed |
| TruVenturo | Series A Extension, Pre Seed, Seed |
| Nexus NeuroTech Ventures | Series A Extension |
| Eclipse Ventures | Series A Extension, Series A |
| Deepwater Asset Management | Pre Seed, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2026
Launched an AI platform for continuous Parkinson's disease symptom tracking.
- Oct 21, 2025
Adam Pellegrini appointed as independent board member.
For institutional investors. Book with your work email.
Rune Labs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Rune Labs's valuation, stock price, and market status.
Is Rune Labs a public or private company?
Rune Labs is a private company.
What is the current stock price of Rune Labs?
Rune Labs is a private company, so its shares have no public market price. Caplight tracks Rune Labs's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Rune Labs worth (valuation)?
Valuation information for Rune Labs is not publicly available.
Can I buy Rune Labs stock?
Rune Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Rune Labs's last funding round?
Rune Labs's most recent funding round was Series A Extension on January 11, 2024.
Who are the main investors in Rune Labs?
Key investors in Rune Labs include DigiTx Partners, Nexus NeuroTech Ventures, Eclipse Ventures.
Will Rune Labs IPO soon?
No public IPO plans have been announced for Rune Labs.
How can I track Rune Labs secondary market activity?
Caplight tracks bids, offers, and trades in Rune Labs's shares on secondary markets.